Scientists test new drug's safety in people with liver issues
NCT ID NCT06812780
Summary
This study looked at how a new drug called AZD2389 is processed by the body in people with different levels of liver problems compared to people with normal liver function. It involved 35 participants who received a single dose of the drug. The main goal was to understand how liver impairment affects the drug's levels in the blood and its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Chandler, Arizona, 85225, United States
-
Research Site
Rialto, California, 92377, United States
-
Research Site
Miami Lakes, Florida, 33014, United States
-
Research Site
Orlando, Florida, 32809, United States
-
Research Site
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.